Triano-Sánchez R, de Prado-Prieto L
Semergen. 2012 Mar;38(2):95-101.
Endometriosis has a prevalence of about 10% and benefits from hormonal contraceptive treatment. It is a chronic and recurrent illness that occurs in fertile women, and is characterised by ectopic endometrial tissue. Clinical manifestations are: infertility, pain and pelvic mass. The goals of the treatment are: relief of symptoms, prevention of progression of disease and the stimulation of fertility. Current treatment options are: Expectant management, analgesia, hormonal therapy, surgery and combined therapies. The use of combined contraceptives is associated with a reduced risk of developing endometriosis, they are also a good choice to prevent pregnancy, and for women with minimal or mild symptoms. Progestins are used for symptomatic endometriosis and as an adjuvant to surgery. The combined contraceptives and the progestins must be considered as a first line treatment.
子宫内膜异位症的患病率约为10%，激素避孕治疗对其有益。它是一种发生在育龄妇女中的慢性复发性疾病，其特征是子宫内膜组织异位。临床表现为：不孕、疼痛和盆腔肿块。治疗目标是：缓解症状、预防疾病进展和促进生育。目前的治疗选择有：期待管理、镇痛、激素治疗、手术及联合治疗。复方避孕药的使用与患子宫内膜异位症风险降低相关，它们也是预防妊娠的良好选择，适用于症状轻微或极轻微的女性。孕激素用于有症状的子宫内膜异位症，并作为手术辅助用药。复方避孕药和孕激素应被视为一线治疗方法。
